Eventide Healthcare & Life Sciences Fund CLASS C SHARES (ETCHX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
31.53
-0.23 (-0.72%)
Aug 5, 2025, 9:30 AM EDT
-0.72%
Fund Assets1.15B
Expense Ratio2.32%
Min. Investment$1,000
Turnover71.00%
Dividend (ttm)n/a
Dividend Yieldn/a
Dividend Growthn/a
Payout Frequencyn/a
Ex-Dividend Daten/a
Previous Close31.76
YTD Return7.49%
1-Year Return-0.44%
5-Year Return-6.82%
52-Week Low23.58
52-Week High33.48
Beta (5Y)n/a
Holdings73
Inception DateDec 27, 2012

About ETCHX

Eventide Healthcare & Life Sciences Fund Class C Shares is a mutual fund that primarily invests in companies operating within the healthcare and life sciences sectors. The fund seeks to achieve long-term capital appreciation by allocating at least 80% of its net assets to equity and equity-related securities of businesses involved in areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, and life science tools. Its portfolio commonly includes both established and emerging firms engaged in innovation across the healthcare landscape, such as drug development, diagnostics, and therapeutics. The fund is actively managed and often holds a concentrated allocation in its top holdings, reflecting a targeted investment approach within its specialized sector. Designed for investors seeking focused exposure to the dynamic healthcare industry, this fund navigates a high-risk, high-reward environment, given the sector’s sensitivity to regulatory changes, research breakthroughs, and market competition. The fund’s Class C shares feature a higher ongoing expense ratio and are suited to investors with a relatively shorter investment horizon due to their fee structure. Overall, the fund plays a significant role in diversifying portfolios with sector-specific growth potential and access to the innovations driving healthcare advancements.

Fund Family Eventide Funds
Category Health
Stock Exchange NASDAQ
Ticker Symbol ETCHX
Share Class Class C Shares
Index S&P Biotechnology Select Industry TR

Performance

ETCHX had a total return of -0.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.61%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
ETIHXClass I Shares1.32%
ETNHXClass N Shares1.52%
ETAHXClass A Shares1.57%

Top 10 Holdings

42.12% of assets
NameSymbolWeight
Verona Pharma plcVRNA5.62%
US BANK MMDA - USBGFS 9n/a5.45%
Insmed IncorporatedINSM5.16%
Guardant Health, Inc.GH4.58%
Mirum Pharmaceuticals, Inc.MIRM4.38%
Axsome Therapeutics, Inc.AXSM4.04%
Blueprint Medicines CorporationBPMC3.44%
Collegium Pharmaceutical, Inc.COLL3.44%
Scholar Rock Holding CorporationSRRK3.42%
Alnylam Pharmaceuticals, Inc.ALNY2.58%